USANA Health Sciences Inc (USNA)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 93,071 91,403 96,426 101,392 107,614 116,568 134,708 159,062 170,192 191,225 195,810 181,676 176,491 168,524 158,627 150,198 146,190 150,187 160,243 180,228
Total assets US$ in thousands 632,757 601,148 602,680 605,533 596,549 556,063 557,959 572,919 577,740 578,946 591,449 584,512 640,887 577,532 512,151 473,750 516,934 463,041 532,401 551,583
Operating ROA 14.71% 15.20% 16.00% 16.74% 18.04% 20.96% 24.14% 27.76% 29.46% 33.03% 33.11% 31.08% 27.54% 29.18% 30.97% 31.70% 28.28% 32.43% 30.10% 32.67%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $93,071K ÷ $632,757K
= 14.71%

The operating return on assets (operating ROA) for USANA Health Sciences Inc has shown a decreasing trend over the past few quarters. From a high of 33.11% in June 2021, it steadily declined to 14.71% in December 2023. This indicates that the company's ability to generate operating income from its assets has weakened over time.

The peak operating ROA of 33.11% in June 2021 suggests that the company was efficient in generating operating income relative to its assets. However, the subsequent decline raises concerns about the company's operational efficiency and profitability.

It is important for USANA Health Sciences Inc to investigate the reasons behind this downward trend in operating ROA and take necessary measures to improve its operational efficiency, asset utilization, and profitability in order to enhance shareholder value and ensure sustainable growth.